TFS Capital’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-333,728
Closed -$824K 583
2017
Q2
$824K Buy
+333,728
New +$768K 0.32% 100
2016
Q3
Sell
-592,849
Closed -$1.86M 1225
2016
Q2
$1.86M Sell
592,849
-202,560
-25% -$675K 0.34% 27
2016
Q1
$2.65M Sell
795,409
-853,674
-52% -$2.66M 0.38% 14
2015
Q4
$5.84M Buy
1,649,083
+868,802
+111% +$3.64M 0.63% 16
2015
Q3
$3.92M Buy
780,281
+197,843
+34% +$1.13M 0.38% 50
2015
Q2
$3.75M Buy
582,438
+7,637
+1% +$51.2K 0.37% 55
2015
Q1
$4.04M Buy
574,801
+389,576
+210% +$2.82M 0.4% 46
2014
Q4
$1.43M Buy
185,225
+122,196
+194% +$967K 0.14% 219
2014
Q3
$471K Sell
63,029
-334,363
-84% -$3.1M 0.04% 617
2014
Q2
$3.85M Buy
397,392
+147,842
+59% +$1.32M 0.3% 65
2014
Q1
$2.07M Sell
249,550
-394,664
-61% -$3.38M 0.14% 217
2013
Q4
$5.44M Buy
644,214
+343,136
+114% +$2.89M 0.26% 93
2013
Q3
$2.4M Sell
301,078
-560,691
-65% -$4.51M 0.11% 272
2013
Q2
$6.65M Buy
+861,769
New +$6.72M 0.28% 61

Other funds holding PDLI